Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by hmmmmmmmmon Oct 24, 2022 1:34pm
235 Views
Post# 35044233

Flu activity

Flu activityThe CDC has flu activity as "High" in NY where Spectral has 2 Tigris sites
Tennessee: "High", 2 sites
Washington DC: "Very High" 1 site
Louisiana: "High" 1 site

The map is turning red for a flu season like we haven't seen in a long time. Spectral has at least 6 Tigris sites that are already in High to Very High activity. And Covid is no longer a valid excuse for the lack testing.

Spectral needs to deliver a substantial increase in patients enrolled.
If they are not able to at least reach their "Worst Case Scenario" of .5 patients per clinic per month or 7 patients per month as promised- it will be clear that their process is the issue.

At 1 million dollars a month we need to see results from management. If they can't deliver over these next 3 months it will be beyond clear that we need a change at the top. Running trials can be difficult, but that's the job at hand. Time for Seto to finally deliver on one of the promises he's made over the last two years.

 
<< Previous
Bullboard Posts
Next >>